...
机译:回复:Tao等人撰写的“通过硫酸纤维素增强HIV感染”。
MRC Clinical Trials Unit, London, United Kingdom.;
Family Health International, Durham, North Carolina.;
Department of Biostatistics, University of Washington, Seattle, Washington.;
MRC Clinical Trials Unit, London, United Kingdom.;
Department of Pathology, University of Oxford, Oxford, United Kingdom.;
Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.;
Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.;
Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.;
University of York, York, United Kingdom.;
MRC Clinical Trials Unit, London, United Kingdom.;
Division of Medicine, Imperial College, London, United Kingdom.;
机译:增强硫酸纤维素对HIV的感染。
机译:简短交流:硫酸纤维素增强HIV感染
机译:对Honge等人的回应:对Gautheret-Dejean等人的评论:区分HIV-1和/或HIV-2感染的快速检测的性能
机译:携带酪氨酸模拟配体的纤维素纳米晶体的合成及α
机译:菲律宾对结构性和个人性艾滋病毒干预措施的评估:利用数学模型估算避免的潜在HIV感染数量和每项避免的感染费用
机译:简短交流:硫酸纤维素增强HIV感染
机译:简短交流:硫酸纤维素增强HIV感染
机译:aCTG 320:一项随机双盲,III期研究的印地那韦硫酸盐(IDV)与开放标签ZDV或司他夫定(d4T)和拉米夫定(3TC)的HIV感染受试者CD4细胞计数<= 200个细胞/ mm3和> = 3个月的Zidovudine Experien